Treatment-refractory mycobacterium avium complex-lung disease (mac-LD)

Clinical trials for Treatment-refractory mycobacterium avium complex-lung disease (mac-LD) explained in plain language.

Never miss a new study

Get alerted when new Treatment-refractory mycobacterium avium complex-lung disease (mac-LD) trials appear

Sign up with your email to follow new studies for Treatment-refractory mycobacterium avium complex-lung disease (mac-LD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New hope for stubborn lung infection: bedaquiline combo shows promise

Disease control Completed

This study tested whether adding bedaquiline to two standard antibiotics (clarithromycin and ethambutol) helps clear a stubborn lung infection called MAC lung disease. 129 adults who had not responded to previous treatment took part. The main goal was to see if the new combinatio…

Matched conditions: TREATMENT-REFRACTORY MYCOBACTERIUM AVIUM COMPLEX-LUNG DISEASE (MAC-LD)

Phase 2/3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC

Treatment-refractory mycobacterium avium complex-lung disease (mac-LD)

Get alerted when new Treatment-refractory mycobacterium avium complex-lung disease (mac-LD) trials appear

New hope for stubborn lung infection: bedaquiline combo shows promise